Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021

Archive ouverte

Tran Kiem, Cécile | Andronico, Alessio | Bosetti, Paolo | Paireau, Juliette | Alter, Lise | Boëlle, Pierre-Yves | Fontanet, Arnaud | Lévy-Bruhl, Daniel | Cauchemez, Simon

Edité par CCSD ; European Centre for Disease Prevention and Control -

International audience. Thrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hospitalisation data and European data on TTS. Across different scenarios, benefits of Vaxzevria distribution in people 55 years and older exceeded the risk of death from COVID-19. In young adults, risks were at least of similar magnitude as benefits.

Suggestions

Du même auteur

Modelling the spread and control of SARS-CoV-2 in France. Modéliser la propagation et le contrôle du SARS-CoV-2 en France

Archive ouverte | Tran Kiem, Cécile | CCSD

The COVID-19 pandemic has had a tremendous impact on societies worldwide. As epidemics are only partially observed processes characterized by non-linear dynamics, their study requires the development of appropriate statistical and...

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22

Archive ouverte | Bosetti, Paolo | CCSD

International audience. Europe has experienced a large COVID-19 wave caused by the Delta variant in winter 2021/22. Using mathematical models applied to Metropolitan France, we find that boosters administered to ≥ 6...

Impact of booster vaccination on the control of COVID-19 in the context of waning immunity: Application to France in the autumn-winter 2021-2022

Archive ouverte | Bosetti, Paolo | CCSD

Europe is confronted with a large COVID-19 wave caused by the Delta variant in autumnwinter 2021-2022. Using a mathematical model applied to Metropolitan France, we find that the hospitalisation peak might be reduced by 25%, 36% a...

Chargement des enrichissements...